Update: Medline Shares Rise After Q3 Beat

02:21 PM EST, 11/04/2026 (MT Newswires) -- (Updates with the company's latest stock move in the headline and first paragraph, and repurchase program in the sixth paragraph.) Medline (MDLN) shares were up nearly 17% in Wednesday trading after the company reported better-than-expected Q3 results. The medical-surgical products provider posted quarterly Q3 adjusted earnings of $0.44 per diluted share. Analysts polled by FactSet expected $0.34. Net sales for the quarter ended Sept. 26 were $7.86 billion, up from $7.12 billion a year earlier. Analysts expected $7.72 billion. Medline said its board has approved a share buyback program, authorizing the repurchase of up to $1 billion of the company's class A stock and/or units of Medline Holdings. Price: 39.73, Change: +5.64, Percent Change: +16.53